Skip to main content

Table 2 Comparisons of the demographic and clinical characteristics of subjects belonging to the schizophrenia (SZ) with and without pre-onset cannabis use disorder (pre-onset CUD)

From: A clinical comparison of schizophrenia with and without pre-onset cannabis use disorder: a retrospective cohort study using categorical and dimensional approaches

 

Total sample

SZ with no pre-onset CUD

SZ with pre-onset CUD

p

Number of subjects

171

140

31

–

Male [n (%)]

114 (67.1%)

84 (60.4%)

30 (96.8%)

<0.001

Mean age at assessment [years (SD)]

34.0 (11.7)

35.4 (12.1)

27.6 (6.8)

0.001

Mean age at onset [years (SD)]

23.7 (7.9)

24.4 (8.5)

20.9 (3.4)

0.027

Mean age at cannabis use onset [years (SD)]

–

–

18.3 (3.7)

–

Mean duration of the illness [years (SD)]

11.5 (11.1)

12.6 (11.7)

6.7 (6.7)

0.007

Mean number of hospital admissions/illness duration

0.6 (0.7)

0.6 (0.8)

0.6 (0.4)

0.82

Personal history of suicide attempts [n (%)]

75 (45.5%)

65 (47.8%)

10 (34.5%)

0.19

Family history of schizophrenia [n (%)]

16 (10.2%)

12 (9.4%)

4 (13.3%)

0.53

Family history of mood disorders [n (%)]

66 (44.0%)

56 (46.3%)

10 (34.5%)

0.25

Family history of suicide attempts [n (%)]

26 (17.6%)

23 (19.3%)

3 (10.3%)

0.25

  1. Significant p values after Bonferroni correction (threshold p < 0.004) are presented in italics
  2. SD standard deviation, n number